VASCEPA Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
VASCEPA General Information
Description
Developer of a prescription medication designed to reduce cardiovascular risk in adults with heart disease or diabetes. The company offers a unique formulation of icosapent ethyl, enabling patients to lower triglyceride levels and reduce the risk of heart attack and stroke, thereby providing financial assistance options for affordability.
Contact Information
Website
www.vascepa.com(Operating Subsidiary)
Corporate Office
- Bedminster Township, NJ 07921
- United States
Corporate Office
- Bedminster Township, NJ 07921
- United States
VASCEPA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
VASCEPA FAQs
-
Where is VASCEPA headquartered?
VASCEPA is headquartered in Bedminster Township, NJ.
-
What industry is VASCEPA in?
VASCEPA’s primary industry is Pharmaceuticals.
-
Is VASCEPA a private or public company?
VASCEPA is a Private company.
-
What is VASCEPA’s current revenue?
The current revenue for VASCEPA is .
-
When was VASCEPA acquired?
VASCEPA was acquired on 01-Jan-2004.
-
Who acquired VASCEPA?
VASCEPA was acquired by Amarin Corporation.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process